Medopad Transforms Deep Vein Disease Treatments
Guy’s and St Thomas’ NHS Foundation Trust is the latest hospital to use Medopad’s Patient Monitoring to help treat patients with venous diseases.
The hospital’s highly specialised vascular team, one of the world’s most respected clinics for deep vein disease management and research, is pioneering the use of Medopad.
The two diseases in question are Post-Thrombotic Syndrome (PTS, which is caused by Deep Vein Thrombosis), and Chronic Venous Insufficiency CVI) – a long-term condition that develops independently of DVT.
Both diseases are incurable and patients are supported by a dedicated multi-disciplinary care team.
The symptoms Medopad’s mobile solution monitors in real-time include pain levels, itching, swelling, varicose veins and in severe cases, ulceration. This data is securely shared with the care team, providing a vital real-time link between both clinicians and patients.
Patients also undergo multiple treatments depending on the severity of their condition - options involve compression stockings or in more developed cases, endovascular procedures and newer surgical reconstruction procedures. Medopad Patient Monitoring is now part of these treatment and recovery plans.
Read about our latest news and achievements.
Johns Hopkins University to Leverage Medopad’s Patient Monitoring Platform and AI Capabilities to Develop New Clinical and Health Innovations
Johns Hopkins University has signed a memorandum of understanding with Medopad to explore new projects using its patient monitoring platform, Artificial Intelligence and Machine Learning capabilities. As part of the University’s Global mHealth Initiative and Technology Innovation Center, the two organisations will also develop joint clinical and public health projects and innovations that leverage Medopad’s technology and expertise.Read More
Healthtech Summit selects Medopad as a Top 20 Digital Health Company in EuropeRead More
and many more...